| |
| |
|
| Insider
Information: |
Ives Jeffrey L. |
| Relationship: |
Director |
| City: |
Shelton |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
47,838 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$36,142 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
47,838 |
|
|
| Total
Value |
$36,142 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cara Therapeutics, Inc. |
CARA |
Director |
2023-06-01 |
47,838 |
|
0 |
Premium* |
|
|
Acumen Pharmaceuticals, Inc. |
ABOS |
Director |
2023-08-17 |
0 |
2023-08-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ABOS |
Acumen Pharmaceuticals, I... |
Director |
– • – |
2023-08-17 |
4 |
AS |
$6.48 |
$272,334 |
D/D |
(41,949) |
0 |
0 |
- |
|
| ABOS |
Acumen Pharmaceuticals, I... |
Director |
– • – |
2023-08-17 |
4 |
OE |
$0.72 |
$31,519 |
D/D |
41,949 |
2,800 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2023-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
32,362 |
47,838 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2022-07-15 |
4 |
AS |
$9.05 |
$32,580 |
D/D |
(3,600) |
15,476 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2022-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
11,876 |
19,076 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2021-06-07 |
4 |
AS |
$13.05 |
$32,886 |
D/D |
(2,520) |
15,380 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2021-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
7,200 |
17,900 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2020-11-19 |
4 |
A |
$15.75 |
$39,373 |
D/D |
2,500 |
10,700 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2020-11-19 |
4/A |
S |
$15.75 |
$39,373 |
D/D |
(2,500) |
10,700 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2020-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
7,200 |
13,200 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2020-06-01 |
4 |
AS |
$16.00 |
$16,000 |
D/D |
(1,000) |
6,000 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2020-06-01 |
4 |
OE |
$9.94 |
$9,940 |
D/D |
1,000 |
7,000 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2020-05-12 |
4 |
AS |
$16.00 |
$40,000 |
D/D |
(2,500) |
6,000 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2020-05-12 |
4 |
OE |
$9.94 |
$24,850 |
D/D |
2,500 |
8,500 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2020-04-21 |
4 |
AS |
$16.00 |
$40,000 |
D/D |
(2,500) |
6,000 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2020-04-21 |
4 |
OE |
$9.94 |
$24,850 |
D/D |
2,500 |
8,500 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2020-03-04 |
4 |
AS |
$16.00 |
$40,000 |
D/D |
(2,500) |
6,000 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2020-03-04 |
4 |
OE |
$9.94 |
$24,850 |
D/D |
2,500 |
8,500 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2020-02-03 |
4 |
AS |
$16.23 |
$40,575 |
D/D |
(2,500) |
6,000 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2020-02-03 |
4 |
OE |
$9.94 |
$24,850 |
D/D |
2,500 |
8,500 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2020-01-02 |
4 |
AS |
$16.13 |
$40,325 |
D/D |
(2,500) |
6,000 |
0 |
% |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2020-01-02 |
4 |
OE |
$9.94 |
$24,850 |
D/D |
2,500 |
8,500 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2019-12-02 |
4 |
AS |
$25.83 |
$64,575 |
D/D |
(2,500) |
6,000 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2019-12-02 |
4 |
OE |
$5.32 |
$13,300 |
D/D |
2,500 |
8,500 |
0 |
- |
|
| CARA |
Cara Therapeutics, Inc. |
Director |
– • – |
2019-11-01 |
4 |
AS |
$20.68 |
$51,700 |
D/D |
(2,500) |
6,000 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
